May 1st-3rd, 2018

London, UK

2018 Speakers

Expand/Collapse

Tuc Ahmad
Scientific Director, Diagnostic Development
Covance

Benoit Canolle
Director, Precision Medicine
Pierre Fabre

Carlos Cara
Head, Medical Immunology International Markets
UCB

Kaan Certel
Head of External Innovation, Oncology
Sanofi

Ruggero De Maria
President
Alliance Against Cancer

Claudia Dollins
Head, Global Regulatory Affairs, Biomarkers & Diagnostics
Merck KGaA

Jörg Engelbergs
Scientific Expert Biomedicines
Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines

Mark Fidock
Vice President & Head, Precision Medicine Laboratories
AstraZeneca

Hugues Malonne
Director General, Post-Authorization
FAHMP

Mirella Marlow
Programme Director, Devices & Diagnostic Systems
NICE

Shane McGann
Senior Manager, Regulatory Affairs
Agios Pharmaceuticals

Mark Roberts
Senior Director, Diagnostics Development
Covance

Dieter Schönwald
Global Technical Officer, IVD
TÜV SÜD

Simon Shohet
Senior Director, Market Access & Pricing
Ipsen

Dominic Smethurst
CMO
Tusk Therapeutics

Andreas Stange
Vice President MHS, Global IVD
TÜV SÜD

Kristin Stieler
Technical & Clinical Product Lead – Europe
Sysmex Inostics

Farhat Syed
Associate Director, Precision Medicine
AstraZeneca

Steen Thaarup
Business Development Manager, Pharma
Unilabs

Tom Turi
Vice President, Companion Diagnostics
Covance

Caoimhe Vallely-Gilroy
Director & Head, Clinical Trials Biosample Management
Merck KGaA

Alan Wookey
Scientific Advisor, Oncology and Companion Diagnostics
Q2 Solutions